Creative Medical Technology Holdings (CELZ) Share-based Compensation (2016 - 2026)

Creative Medical Technology Holdings (CELZ) has reported Share-based Compensation for 9 consecutive years, with $11183.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation changed 0.0% year-over-year to $11183.0 in Q2 2026; TTM through Jun 2026 was $11183.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $11183.0, down 69.49% from the prior year.
• Share-based Compensation was $11183.0 for Q2 2026 at Creative Medical Technology Holdings, down from $60000.0 in the prior quarter.
• Over five years, Share-based Compensation peaked at $23.0 million in Q2 2022 and troughed at $9162.0 in Q4 2022.
• A 5-year average of $2.7 million and a median of $11183.0 in 2023 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation jumped 10746.43% in 2022 and plunged 99.95% in 2023, its largest moves.
• Over 5 years, Share-based Compensation stood at $9162.0 in 2022, then changed by 0.0% to $9162.0 in 2023, then changed by 0.0% to $9162.0 in 2024, then advanced by 22.06% to $11183.0 in 2025, then changed by 0.0% to $11183.0 in 2026.
• The last three Share-based Compensation figures came in at $11183.0 (Q2 2026), $60000.0 (Q1 2026), and $11183.0 (Q3 2025), per Business Quant data.